Iniparib (BSI-201) CAS 160003-66-7 4-Iodo-3-Nitrobenzamide Puritas ≥98.0% (HPLC)

Description:

Nomen chemicum: 4-Iodo-3-Nitrobenzamide

Synonyma: Iniparib;BSI-201

CAS: 160003-66-7

Puritas: ≥98.0% (HPLC)

Aspectus: lux Yellow ad Yellow pulverem

Contactus: Dr

Mobile/Wechat/Whatsapp: +86-15026746401

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica 4-Iodo-3-Nitrobenzamide (Iniparib; BSI-201) (CAS: 160003-66-7) cum magna qualitate.Ruifu Chemical traditio totius terrarum, quantitatis competitive pretium, optimum servitium, parvas et moles in promptu habere potest.Purchase Iniparib (BSI-201).Please contact: alvin@ruifuchem.com

Chemical Properties:

Nomen chemicum	4-Iodo-3-Nitrobenzamide
Synonyma	Iniparib;BSI-201;BSI201;NSC-746045;IND-71677
Stock Status	In Stock
CAS Number	16003-66-7
Formulae hypotheticae	C7H5IN2O3
M. Pondus	292.03 g/mol
Ferveret	344.8±32.0℃
Density	2.055±0.06 g/cm3
Repono Nativ.	Frigus & siccum (2~8℃)
COA & MSDS	Praesto
Brand	Ruifu Chemical

Specifications:

Items	Signa inspectionis	Proventus
Aspectus	Lux Yellow ad Yellow pulverem	Obsequitur
Puritas / Analysis Methodus	≥98.0% (HPLC)	>98.0%
NMR Imaginum	Conformat ut Structure	Obsequitur
conclusio	Productum probatum & obsequitur cum specificationibus

Sarcina / at /naviportans:

Sarcina:Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Condite in arcte clauso vase.Condite in loco frigido, sicco (2~8℃) et cellario bene ventilato ab substantiis incompossibilibus.A luce et humore protege.
Naviportans:Libera ad mundum ab aere, per FedEx / DHL Express.Ieiunium et certas traditiones provide.

commoda:

Satis capacitas: sufficientes facilities et technici

Professional Service: One stop acquireing service

Altera Package: Custom sarcina ac titulus praesto

Ieiunium Delivery: Si intra stirpem, tres dies partus praestatur

Supple firmum: Esse rationabile stirpe

Technical Support: Technology solution praesto

Custom Synthesis Service: Range from P. to kilos

High Quality: Constitutus ratio completa qualitas certitudinis

FAQ:

Quam mercari?Quaeso contactumDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com

15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.

Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Coream, Iaponicam, Australiam etc.

Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.

Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.

Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.

Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.

MOQ?Nec MOQ.Parvus ordo placet.

Tempus adferendi? Si intus prosapia, tres dies partus praestatur.

Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.

Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.

Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.

Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.

160003-66-7 - Periculum et Salus;

Periculosam symbola Xn - Noxia
Periculum Codes
R22 - noxia absorptus
R36 - irritans ad oculos
R43 - Sit causa cutis contactus sentiendi
Salus Descriptio
XXVI - In contactu cum oculis, statim cum aqua multa accende et quaerere consilium medicinae.
WGK Germania 3

Applicatio:

4-Iodo-3-Nitrobenzamide (Iniparib; BSI-201) (CAS: 160003-66-7) immedicabile est inhibitor.Studia ostendunt potentialem agentis medicinalem ad curationem cancri, incluso triplo-negativo, carcinomate.Iniparib est antineoplasticum primum polymerasum-1 (PARP-1) inhibitorem (ADP-ribosum) esse putavit.Recentes studia indicant Iniparib-parp-1 inhibitorem non esse, et eius mechanismus actionis in praesenti incognita est.